HIV

Human trials point the way towards an mRNA vaccine against HIV

by

Electron micrograph of the HIV pathogen Scott Camazine / Alamy Stock Photo Generating effective protection against HIV may require a complex vaccine consisting of a series of different viral proteins. Now, two trials of the potential components delivered via mRNA have produced promising results. The hope is mRNA technology will make it possible to deliver … Read more

FDA Approves a Twice-Yearly Shot to Prevent HIV

by

On June 18, the U.S. Food and Drug Administration (FDA) approved the first medicine to prevent HIV that only has to be taken twice a year. People who are at high risk for HIV can now take the injection—called lenacapavir and sold as Yeztugo—just once every six months. The approval is a milestone in the … Read more